The evolving role of intravenous leukotriene modifiers in acute asthma

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2, 2010, Pages 381-382

  Hallstrand, Teal S ^a   Henderson Jr , William R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acute asthma; anticholinergic bronchodilator; asthma exacerbation; intravenous medication; leukotriene receptor antagonist; randomized trial

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; MONTELUKAST; PLACEBO; PREDNISONE; SALBUTAMOL; ZAFIRLUKAST;

ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DRUG TREATMENT FAILURE; EDITORIAL; EMERGENCY WARD; FORCED EXPIRATORY VOLUME; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LUNG FUNCTION; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELAPSE; UNITED STATES;

ASTHMA; HUMANS; INJECTIONS, INTRAVENOUS; LEUKOTRIENE ANTAGONISTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 75849139980     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.12.991     Document Type: Editorial

References (15)

1. Camargo Jr. C.A., Gurner D.M., Smithline H.A., Chapela R., Fabbri L.M., Green S.A., et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 125 (2010) 374-380
2. Camargo Jr. C.A., Smithline H.A., Malice M.P., Green S.A., and Reiss T.F. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 167 (2003) 528-533
3. FitzGerald J.M. Broadening the therapeutic options in acute asthma. Am J Respir Crit Care Med 167 (2003) 488-489
4. Rodrigo G.J., and Rodrigo C. Intravenous montelukast in acute asthma. Am J Respir Crit Care Med 169 (2004) 130-131
5. Rodrigo G.J., and Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 161 (2000) 1862-1868
6. Silverman R.A., Nowak R.M., Korenblat P.E., Skobeloff E., Chen Y., Bonuccelli C.M., et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest 126 (2004) 1480-1489
7. Dworski R., Fitzgerald G.A., Oates J.A., and Sheller J.R. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 149 (1994) 953-959
8. Dockhorn R.J., Baumgartner R.A., Leff J.A., Noonan M., Vandormael K., Stricker W., et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 55 (2000) 260-265
9. Nelson K.A., Smith S.R., Trinkaus K., and Jaffe D.M. Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years. Pediatr Emerg Care 24 (2008) 21-27
10. Mougey E.B., Feng H., Castro M., Irvin C.G., and Lima J.J. Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics 19 (2009) 129-138
11. Hallstrand T.S., and Henderson Jr. W.R. An update on the role of leukotrienes in asthma. Curr Opin Allergy Clin Immunol 10 (2010) 60-66
12. Malmstrom K., Rodriguez-Gomez G., Guerra J., Villaran C., Pineiro A., Wei L.X., et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 130 (1999) 487-495
13. 4, increased airway inflammatory cells in subjects with atopic asthma. Am J Respir Crit Care Med 164 (2001) 1495-1500
14. 4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors. Proc Natl Acad Sci U S A 105 (2008) 16695-16700
15. 4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med 206 (2009) 2543-2555